Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.

SD Medical Cannabis Allowed Forms — Flower, Edibles, Vapes, Concentrates

SD allows the standard product spectrum: flower, pre-rolls, edibles, tinctures, topicals, vape cartridges, and concentrates. Among the broadest allowed-form slates of any U.S. medical-cannabis program. Edibles serving-size THC limits set by ARSD (commonly 10 mg per serving). No statutory THC potency cap on flower or concentrates — rejected 6–1 / 7–0 in 2026.

Last verified: May 2026

The Allowed Product Slate

SD-licensed manufacturers and dispensaries offer the full standard product spectrum:

  • Flower — eighths (3.5 g), quarters (7 g), and ounces (28 g).
  • Pre-rolls and infused pre-rolls.
  • Edibles — gummies, chocolates, baked goods, beverages, with serving-size THC limits set by ARSD (commonly 10 mg per serving).
  • Tinctures and oral oils.
  • Topicals — creams, balms, lotions.
  • Vape cartridges and disposable pens.
  • Concentrates — distillate, live resin, sauce, sugar, shatter, diamonds.

The SD product slate is broader than restrictive medical-only programs (Alabama’s Compassion Act allows only tablets, capsules, tinctures, gels, suppositories, transdermal patches, and nebulizer solution — no flower, no edibles, no vape carts). It is comparable to MN, MT, and other adult-use programs in product breadth.

Quality Control and Testing

All SD-licensed cannabis products must undergo state-licensed laboratory testing for:

  • Cannabinoid profile (THC, CBD, minor cannabinoids).
  • Pesticide residue.
  • Heavy metals (lead, cadmium, arsenic, mercury).
  • Microbial contamination (yeast, mold, aspergillus, bacterial counts).
  • Solvent residues for solvent-extracted products.
  • Mycotoxins.

SDDOH licenses the testing labs (2–6 active labs as of 2026, including the state lab plus private labs). Testing labs must be third-party — operators may not also hold a testing license.

Labeling Requirements

SD-licensed products must be labeled with:

  • Total THC content per dose form and per package.
  • Total CBD content (and other major cannabinoids if relevant).
  • Lot number and manufacturing date.
  • Expiration date.
  • Cultivator and processor identification.
  • Patient-direction information (suggested dosing, route, frequency).
  • Contraindications and adverse-event warnings.
  • The SDDOH verification seal.

Packaging must be child-resistant under federal Poison Prevention Packaging Act standards.

The Concentrate-Felony Pitfall for Non-Cardholders

An important asymmetry: while licensed dispensaries lawfully sell concentrates and vape cartridges to registered patients, concentrate possession by a non-cardholder — or by a cardholder outside the rolling-window cap — is a Class 4 felony under SDCL § 22-42-2 with a 1-year mandatory minimum on first conviction. The legal status of concentrate at the point of purchase (legal medical cannabis) does not extend to non-cardholder transport, sharing, or post-cap possession. See trafficking page.

Edibles — The 10 mg/Serving Standard

Edible products are typically formulated at 10 mg of THC per serving, with multiple servings per package. The 10 mg/serving standard is consistent with most U.S. medical-cannabis programs. Beverages, baked goods, gummies, and chocolates all conform to the per-serving rule. Total package THC counts toward the patient’s 14-day rolling-window cap.

Comparison with Border States

  • Minnesota: similar product slate; adult-use since Aug 2023; first state-licensed retail Sept 2025.
  • Montana: similar product slate; adult-use since Jan 2022.
  • North Dakota: medical only; restricted product slate (no smokable flower in some configurations).
  • Iowa: medical CBD only; no THC products.
  • Wyoming: no medical / no rec.

Related on this site: SD Has No Potency Caps, SD Medical Cannabis Taxation, Send a Message.